Skip to main content

venBio Partners LLC

SEC CIK
0001776382
Latest filing
Aug 14, 2026

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
9
−1 vs. Q2 2021
Portfolio value
$1.00B
+$156.5M (+18.5%) vs. Q2 2021
Filed
Nov 15, 2021
SEC
Holdings of venBio Partners LLC in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
ALXOAlx Oncology Holdings IncCOM9,699,925$716.4M71.4%00.0%UnchangedHistory
HRMYHarmony Biosciences Holdings, Inc.COM3,063,194$117.4M11.7%−441,430−12.6%ReducedHistory
AKROAkero Therapeutics, Inc.COM2,200,778$49.2M4.9%00.0%UnchangedHistory
PHVSPharvaris N.V.COM2,303,310$40.8M4.1%00.0%UnchangedHistory
IMPLIPI Legacy Liquidation CoCOM2,759,791$33.6M3.3%00.0%UnchangedHistory
ELEVElevation Acquisition Group Inc.COM2,608,167$20.3M2.0%00.0%UnchangedHistory
CMPICheckmate Pharmaceuticals, Inc.COM3,673,374$14.6M1.5%00.0%UnchangedHistory
MTCRMetacrine, Inc.COM3,059,123$10.5M1.0%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS161,897$887.0K0.1%00.0%UnchangedHistory

Sold out since Q2 2021 (1)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of venBio Partners LLC sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
APLSApellis Pharmaceuticals, Inc.COM411,471$26.0M3.1%History